Circumsporozoite (CS) antibodies have been shown to be reliable indicators of malaria transmission in endemic areas. Their prevalence in travelers can indicate the degree of exposure to plasmodial infection. Two hundred sixty-two short-term travelers to Kenya were recruited to a prospective study to determine the incidence of CS antibody conversion. All travelers were receiving malaria chemoprophylaxis. Serum samples were drawn before departure and 4 -6 weeks after their return to Germany. Sera from 310 volunteers who did not leave Germany served as controls. Serum specimens from 13 (4.96%) of the 262 travelers were found to be positive after return. None of the travelers developed symptoms of clinical malaria or antibodies against the blood stages of Plasmodium falciparum. All 310 control samples tested negative. These data demonstrate a considerable risk of malaria transmission for short-term travelers to East Africa.
In people exposed to Plasmodium falciparum transmission, sion criteria were as follows: residency in Germany for ú10 some of the anti-sporozoite antibodies in their sera are directed years, planned journey to Kenya for at least 7 days and not against a main surface protein, the circumsporozoite protein (CS exceeding 6 weeks, no history of previous malaria, intake of protein). Therefore, the detection of significant antibody titers sufficient malaria chemoprophylaxis during and 4 weeks after to CS protein in a person indicates previous inoculation with their journey, and informed consent. Only tourists traveling to sporozoites, but not necessarily the development of disease.
East Africa for a hotel stay at the coast were recruited. Serum In persons living in areas of endemicity, prevalence and levels specimens were drawn from each participant before departure of CS antibodies have been shown to correlate with the entomoand within 4 -6 weeks after return. Malaria was excluded in logical inoculation rate and to serve as an indicator of transmisall participants by thin and thick blood smears as well as by a sion [1] [2] [3] [4] . The sensitivity and specificity of an available ELISA negative immunofluorescence antibody test (IFAT). Negative system have been evaluated in nonimmune patients after one controls consisted of 310 volunteers who had never been to episode of clinical malaria [5] . Whereas the sensitivity was found malarious areas. to be rather low (55.8% during a period of 8-90 days after
Methods. Antibodies against the immunodominant epitope onset of symptoms), its specificity was assessed at 100%. of the P. falciparum CS protein, the highly conserved tandem Risk estimates for malaria incidence in unprotected travelers repeat of amino acids (NANP) were determined by a to West and East Africa have been Ç2% -3% per month [6] .
(NANP) 40 -ELISA (Sclavo Dignostici, Siena, Italy) as pre-A study involving 222 patients presenting after return from subviously described [8] . By use of calibration sera with defined Saharan Africa demonstrated a surprisingly high prevalence of international extinction units (IEU), the cutoff value for mea-CS antibodies among individual travelers: 48.8% were found surement of CS antibodies was defined as 6.25 IEU [8] . to be positive, whereas this was true for only 5.6% of package All sera were also examined by an IFAT to determine levels tourists [7] . However, no pre-travel sera were available from of antibody to merozoites of P. falciparum derived from continthese patients to verify seroconversion.
uous culture. Titers of 1:64 and higher were considered positive To estimate the actual infection pressure among short-term [9 -11] . travelers to East Africa, we investigated the incidence of seroStatistical analysis was done with x 2 test by use of Epi Info conversion of CS antibodies in a representative group of tourists. version 6.0 software (CDC, Atlanta).
Materials and Methods Results
Patients. Altogether, 289 travelers were recruited to this study from our travel clinic during a period of 3 months. IncluOf the 289 recruited travelers, 262 (90.7%) could be followed up after their return to Germany. For these 262 remaining travelers (117 male, 145 female; average age, 35.5 years; range, Nothdurft et al. CID 1999; 28 (March) All serum samples drawn before departure were CS antivention measures. By screening of symptomatic and asymptomatic travelers, more reliable data regarding the risk of mabody -negative. After the travelers' return from East Africa, 13 (4.96%) of the 262 serum specimens investigated were found to laria transmission in travelers, and, therefore, the true necessity of malaria chemoprophylaxis in various endemic areas, could be positive, while 249 (95.04%) remained negative. Testing for merozoite antibodies by IFAT yielded negative results in be obtained. all specimens.
Travelers with positive and negative reactions in the CS
